블로그

• Cardiovascular, cancer, and infection risks of Janus kinase inhibitors in rheumatoid arthritis ... Evolving evidence suggests that patients undergoing treatment with Janus kinase inhibitors (JAKi) may face tumor necrosis factor inhibitor (TNFi) use, which served as the active comparator, in patients with rheumatoid blog.naver.com · 2025.06.16